Personalizing Whole Genome Sequencing Doubles Diagnosis of Rare Diseases
Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases.
Read MorePosted by Andy Lundin | Nov 8, 2022 | Sequencing Systems |
Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases.
Read MorePosted by Andy Lundin | Nov 7, 2022 | Breast |
MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality.
Read MorePosted by Andy Lundin | Oct 28, 2022 | Diagnostic Technologies |
The organizations have established an exclusive license agreement to any diagnostic techniques utilizing imprintome control regions.
Read MorePosted by Andy Lundin | Oct 27, 2022 | Molecular Diagnostics |
Sema4 presented research to debunk the belief that exome and genome sequencing deliver more inconclusive results than multi-gene panels.
Read MorePosted by Andy Lundin | Oct 26, 2022 | Respiratory Disease |
Cystic fibrosis is often missed in newborn screenings for non-white babies, creating higher risk for other races.
Read More